# Vosevi

NDC: 61958-2401
Generic name: SOFOSBUVIR, VELPATASVIR, and VOXILAPREVIR
Labeler / Manufacturer: Gilead Sciences, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20170718

FDA application: NDA209195

## Active ingredients

- SOFOSBUVIR: 400 mg/1
- VELPATASVIR: 100 mg/1
- VOXILAPREVIR: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"61958-2401"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=61958-2401
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=17ffc094-8ca7-45d2-80d8-fd043bc9a221